We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Bio-Rad Laboratories Class A
BIO
$9.42B
| $33.2M | 0.01% |
79,703
-1,453
| -2% | -$724K |
|
702
Matador Resources
MTDR
$6.09B
| $33.2M | 0.01% |
678,725
-145,169
| -18% | -$7.84M |
|
703
Steven Madden
SHOO
$3.55B
| $33M | 0.01% |
1,237,672
-135,392
| -10% | -$4.26M |
|
704
SPX Corp
SPXC
$10.8B
| $32.9M | 0.01% |
596,446
-112,371
| -16% | -$6.43M |
|
705
Weatherford International
WFRD
$6.22B
| $32.9M | 0.01% |
1,019,967
+55,415
| +6% | +$1.38M |
|
706
Douglas Emmett
DEI
$1.96B
| $32.9M | 0.01% |
1,836,497
+310,695
| +20% | +$6.62M |
|
|
SPR
707
DELISTED
Spirit AeroSystems
SPR
| $32.9M | 0.01% |
1,500,611
+527,734
| +54% | +$16M |
|
708
Celanese
CE
$4.82B
| $32.8M | 0.01% |
363,281
-26,189
| -7% | -$2.88M |
|
709
Elastic
ESTC
$7.81B
| $32.7M | 0.01% |
456,290
+15,209
| +3% | +$1.21M |
|
710
Sanmina
SANM
$10.9B
| $32.7M | 0.01% |
709,755
-72,601
| -9% | -$3.38M |
|
711
Pultegroup
PHM
$25.3B
| $32.7M | 0.01% |
872,000
-37,512
| -4% | -$1.58M |
|
712
VF Corp
VFC
$5.89B
| $32.7M | 0.01% |
1,092,576
-109,146
| -9% | -$4.71M |
|
713
Lithia Motors
LAD
$8.26B
| $32.6M | 0.01% |
152,095
-5,373
| -3% | -$1.4M |
|
714
Starwood Property Trust
STWD
$6.09B
| $32.5M | 0.01% |
1,785,997
-167,141
| -9% | -$3.79M |
|
715
Elanco Animal Health
ELAN
$11.1B
| $32.5M | 0.01% |
2,618,694
+706,320
| +37% | +$12.3M |
|
716
Alkermes
ALKS
$8.25B
| $32.5M | 0.01% |
1,455,160
-134,732
| -8% | -$3.5M |
|
717
Otter Tail
OTTR
$3.94B
| $32.5M | 0.01% |
528,139
-35,665
| -6% | -$2.57M |
|
718
Old National Bancorp
ONB
$10.2B
| $32.4M | 0.01% |
1,966,903
+440,759
| +29% | +$7.37M |
|
|
Y
719
DELISTED
Alleghany Corp
Y
| $32.2M | 0.01% |
38,365
-1,347
| -3% | -$1.13M |
|
720
Federal Signal
FSS
$7.83B
| $32.2M | 0.01% |
862,217
-4,565
| -0.5% | -$179K |
|
|
CHX
721
DELISTED
ChampionX
CHX
| $32.1M | 0.01% |
1,642,606
+116,196
| +8% | +$2.4M |
|
722
Selective Insurance
SIGI
$5.73B
| $32M | 0.01% |
393,568
-13,403
| -3% | -$1.09M |
|
|
SJI
723
DELISTED
South Jersey Industries, Inc.
SJI
| $32M | 0.01% |
958,491
-71,496
| -7% | -$2.44M |
|
724
Lumen
LUMN
$6.44B
| $31.8M | 0.01% |
4,374,128
+40,417
| +0.9% | +$411K |
|
725
SentinelOne
S
$7.34B
| $31.8M | 0.01% |
1,245,738
+506,124
| +68% | +$13.3M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.